中文产业新闻精选评分70Chinese source
艾伯维约109亿美元收购Apogee Therapeutics，获得IL-13单抗zumilokibart等后期管线
跨国药企密集买入，瞄准成熟管线
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
跨国药企密集买入，瞄准成熟管线
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.